BASF Pharma Solutions has announced a global price increase of up to 20 per cent on excipients and selected APIs, effective immediately or as contracts permit.
The move reflects rising energy and raw material costs, while supporting reliable supply of high-quality pharmaceutical inputs.
The company will continue to assess market conditions and update pricing as required.